Adipocyte Mineralocorticoid Receptor.
Adipose tissue
Adrenal glands
Aldosterone
Browning
Metabolic syndrome
Obesity
Journal
Vitamins and hormones
ISSN: 0083-6729
Titre abrégé: Vitam Horm
Pays: United States
ID NLM: 0413601
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
26
1
2019
pubmed:
27
1
2019
medline:
23
4
2019
Statut:
ppublish
Résumé
Mineralocorticoid receptor (MR) has been recently identified in adipose tissue, where its excessive activation contributes to several metabolic derangements often observed in obesity and metabolic syndrome. Recent findings support the existence of a bidirectional cross-talk between adipose tissue and adrenal glands, contributing to obesity-related hyperaldosteronism and subsequent adipocyte MR excessive activation. In this regard, MR pharmacological blockade has led to prevention of weight gain and metabolic benefits in murine models of genetic or diet-induced obesity. However, there is still a lack of knowledge on the potential metabolic effects of MR antagonists in clinical settings. Hence, larger clinical studies are deemed necessary to clarify the role of MR antagonism in obesity and metabolic syndrome in humans.
Identifiants
pubmed: 30678856
pii: S0083-6729(18)30077-3
doi: 10.1016/bs.vh.2018.10.005
pii:
doi:
Substances chimiques
Mineralocorticoid Receptor Antagonists
0
Receptors, Mineralocorticoid
0
Aldosterone
4964P6T9RB
Cytochrome P-450 CYP11B2
EC 1.14.15.4
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
189-209Informations de copyright
© 2019 Elsevier Inc. All rights reserved.